XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 29, 2018
Sep. 30, 2017
Sep. 29, 2018
Sep. 30, 2017
Revenues:        
Research and development revenues $ 1,482,711 $ 549,765 $ 3,563,341 $ 1,942,819
Revenues 5,126,330 6,139,167 16,723,848 16,444,764
Expenses:        
Research and development 4,599,266 5,253,860 13,577,075 14,213,950
Selling, general and administration 7,166,137 5,344,999 21,011,050 16,186,946
Total expenses 15,425,203 14,743,743 45,807,866 41,780,363
Loss from operations (10,298,873) (8,604,576) (29,084,018) (25,335,599)
Other income and expense:        
Interest income 160,875 191,613 486,239 611,532
Other income 241,466 (109,546) 1,360,822 215,883
Foreign currency transaction (losses) gains (227,447) 224,370 (254,615) (410,373)
Gain on investments 0 0 2,849,816 274,000
Total other income and expense 174,894 306,437 4,442,262 691,042
Loss before (provision) benefit for income taxes and net loss (income) attributable to noncontrolling interest (10,123,979) (8,298,139) (24,641,756) (24,644,557)
Tax (provision) benefit 316,000 (4,500) 115,000 1,141,500
Net loss (9,807,979) (8,302,639) (24,526,756) (23,503,057)
Net loss (income) attributable to noncontrolling interest 16,596 55,217 (41,862) 65,223
Net loss attributable to Kopin Corporation $ (9,791,383) $ (8,247,422) $ (24,568,618) $ (23,437,834)
Net (loss) income per share        
Basic and diluted (usd per share) $ (0.13) $ (0.11) $ (0.34) $ (0.34)
Weighted average number of common shares        
Basic and diluted (in shares) 73,135,253 72,187,688 73,102,979 69,117,640
Product [Member]        
Revenues:        
Research and development revenues $ 1,482,711   $ 3,563,341  
Revenues 3,643,619 $ 5,589,402 13,160,507 $ 14,501,945
Other income and expense:        
Cost of Goods and Services Sold 3,659,800 $ 4,144,884 11,219,741 $ 11,379,467
Net loss attributable to Kopin Corporation $ (9,791,383)   $ (24,568,618)